Holdings
Avoro Capital Advisors LLC
As of Jun 30, 2026, Avoro Capital Advisors LLC reported 22 positions worth US$9.06B. Largest: United Therapeutics Corporation, Krystal Biotech, Inc. and Madrigal Pharmaceuticals, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| United Therapeutics Corporation | 2.78M | US$1.51B | +148K | Jun 30, 2026 |
| Krystal Biotech, Inc. | 2.89M | US$1.07B | no change | Jun 30, 2026 |
| Madrigal Pharmaceuticals, Inc. | 1.83M | US$984M | +15,152 | Jun 30, 2026 |
| Argenx Se | 1M | US$928M | no change | Jun 30, 2026 |
| Arrowhead Pharmaceuticals, Inc. | 11.4M | US$926M | +656K | Jun 30, 2026 |
| Kymera Therapeutics, Inc. | 7.47M | US$857M | no change | Jun 30, 2026 |
| Revolution Medicines, Inc. | 2.3M | US$430M | −47,444 | Jun 30, 2026 |
| Cytokinetics, Incorporated | 5M | US$426M | +1.67M | Jun 30, 2026 |
| Celcuity Inc. | 3.4M | US$356M | +25,000 | Jun 30, 2026 |
| Xenon Pharmaceuticals Inc. | 5.78M | US$349M | no change | Jun 30, 2026 |